SEC Form 4 · accession 0001140361-15-035596
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andre Walker
Officer — Senior VP,Research&Development
Period of report
Sep 17, 2015
Accepted (ET)
Sep 21, 2015 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 17, 2015 | M | 4,000 | $0.96 | A | 4,000 | D | |
| Common Stock | Sep 17, 2015 | S | 1,000 | $48.00 | D | 3,000 | D | |
| Common Stock | Sep 17, 2015 | S | 1,000 | $50.00 | D | 2,000 | D | |
| Common Stock | Sep 17, 2015 | S | 1,000 | $52.00 | D | 1,000 | D | |
| Common Stock | Sep 17, 2015 | S | 1,000 | $53.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $0.96 | Sep 17, 2015 | M | 4,000 | D | — | Dec 12, 2017 | Common Stock | 4,000 | 11,302 | D |
Explanation of responses
- F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 28, 2015.
- F2100% of the shares subject to the option are fully vested and exercisable.